These highlights do not include all the information needed to use KOĀTE ® safely and effectively. See full prescribing information for KOĀTE. KOĀTE ® , Antihemophilic Factor (Human) Lyophilized Powder for Solution for Intravenous Injection Initial U.S. Approval: 1974
These highlights do not include all the information needed to use KOĀTE ® safely and effectively. See full prescribing information for KOĀTE. KOĀTE ® , Antihemophilic Factor (Human) Lyophilized Powder for Solution for Intravenous Injection Initial U.S. Approval: 1974
antihemophilic factor, human 1 UNT Injection [Koate]
SBD
23
These highlights do not include all the information needed to use KOĀTE ® safely and effectively. See full prescribing information for KOĀTE. KOĀTE ® , Antihemophilic Factor (Human) Lyophilized Powder for Solution for Intravenous Injection Initial U.S. Approval: 1974
antihemophilic factor, human 1 UNT Injection [Koate]
SBD
10
These highlights do not include all the information needed to use KOĀTE ® safely and effectively. See full prescribing information for KOĀTE. KOĀTE ® , Antihemophilic Factor (Human) Lyophilized Powder for Solution for Intravenous Injection Initial U.S. Approval: 1974
These highlights do not include all the information needed to use KOĀTE ® safely and effectively. See full prescribing information for KOĀTE. KOĀTE ® , Antihemophilic Factor (Human) Lyophilized Powder for Solution for Intravenous Injection Initial U.S. Approval: 1974
These highlights do not include all the information needed to use KOĀTE ® safely and effectively. See full prescribing information for KOĀTE. KOĀTE ® , Antihemophilic Factor (Human) Lyophilized Powder for Solution for Intravenous Injection Initial U.S. Approval: 1974